• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 PI3K 抑制剂 BENC-511 对人肺腺癌细胞 A549 增殖和凋亡的影响。

Effects of BENC-511, a novel PI3K inhibitor, on the proliferation and apoptosis of A549 human lung adenocarcinoma cells.

机构信息

Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University.

Department of Pharmacology, Shandong College of Traditional Chinese Medicine.

出版信息

Biosci Trends. 2019;13(1):40-48. doi: 10.5582/bst.2019.01006.

DOI:10.5582/bst.2019.01006
PMID:30867372
Abstract

The small chemical compound 8-ethoxy-2-(4-fluorophenyl)-3-nitro-2H-chromene (S14161) was recently identified as an inhibitor of phosphoinositide 3-kinase (PI3K) and reported to inhibit tumor growth. However, its chiral structure and poor solubility prevent its further use. Compound 6-bromo-8-ethoxy-3-nitro-2H-chromene (BENC-511) is an analogue of S14161 produced by structural optimization. A previous study indicated that BENC-511 acted on multiple myeloma and that it had a toxicity by inhibiting the PI3K/protein kinase B (Akt) pathway. However, the effects of BENC-511 on the proliferation and apoptosis of A549 human lung adenocarcinoma cells have not been reported. The current study investigated the effects of BENC-511 on the proliferation and apoptosis of A549 cells in vitro. Results indicated that the compound BENC-511 inhibited the viability of A549 cells in a concentration- and time- dependent manner. BENC-511 suppressed proliferation and colony formation via S phase arrest. BENC-511 decreased the expression of cyclin A, proliferating cell nuclear antigen (PCNA), B-cell lymphoma-2 (Bcl-2), phospho-mammalian target of rapamycin (p-mTOR), and phospho-Akt (p-Akt) and it increased the expression of p21WAF1CIP1(p21), Caspase-3 and Caspase-9. In conclusion, BENC-511 inhibited the proliferation of A549 human lung adenocarcinoma cells via S phase arrest as a result of up-regulation of p21 and reduction of Cyclin A/cyclin-dependent kinase 2 (CDK2)/PCNA complex and it induced apoptosis by reducing the mitochondrial membrane potential via the Akt/Bcl-2/Caspase-9 mitochondrial pathway of apoptosis.

摘要

小分子化合物 8-乙氧基-2-(4-氟苯基)-3-硝基-2H-色烯(S14161)最近被鉴定为磷酸肌醇 3-激酶(PI3K)的抑制剂,并被报道能抑制肿瘤生长。然而,其手性结构和较差的溶解度阻碍了其进一步的应用。化合物 6-溴-8-乙氧基-3-硝基-2H-色烯(BENC-511)是 S14161 的结构优化类似物。先前的研究表明,BENC-511 作用于多发性骨髓瘤,通过抑制 PI3K/蛋白激酶 B(Akt)通路发挥毒性作用。然而,BENC-511 对 A549 人肺腺癌细胞增殖和凋亡的影响尚未报道。本研究探讨了 BENC-511 对 A549 细胞体外增殖和凋亡的影响。结果表明,该化合物 BENC-511 呈浓度和时间依赖性地抑制 A549 细胞活力。BENC-511 通过 S 期阻滞抑制增殖和集落形成。BENC-511 降低了细胞周期蛋白 A、增殖细胞核抗原(PCNA)、B 细胞淋巴瘤-2(Bcl-2)、磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)和磷酸化 Akt(p-Akt)的表达,增加了 p21WAF1CIP1(p21)、Caspase-3 和 Caspase-9 的表达。综上所述,BENC-511 通过上调 p21 和降低细胞周期蛋白 A/细胞周期蛋白依赖性激酶 2(CDK2)/PCNA 复合物,通过抑制 Akt/Bcl-2/Caspase-9 线粒体凋亡途径降低线粒体膜电位,抑制 A549 人肺腺癌细胞增殖,并诱导凋亡。

相似文献

1
Effects of BENC-511, a novel PI3K inhibitor, on the proliferation and apoptosis of A549 human lung adenocarcinoma cells.新型 PI3K 抑制剂 BENC-511 对人肺腺癌细胞 A549 增殖和凋亡的影响。
Biosci Trends. 2019;13(1):40-48. doi: 10.5582/bst.2019.01006.
2
Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization.通过结构优化鉴定一种有前景的用于治疗多发性骨髓瘤的PI3K抑制剂。
J Hematol Oncol. 2014 Jan 15;7:9. doi: 10.1186/1756-8722-7-9.
3
Preparation of S14161 and its analogues and the discovery of 6-bromo-8-ethoxy-3-nitro-2H-chromene as a more potent antitumor agent in vitro.S14161 及其类似物的制备和发现 6-溴-8-乙氧基-3-硝基-2H-色烯作为更有效的体外抗肿瘤剂。
Bioorg Med Chem Lett. 2013 Jun 1;23(11):3314-9. doi: 10.1016/j.bmcl.2013.03.097. Epub 2013 Apr 4.
4
A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3.一种新型的 PI3K 抑制剂对源自 PC3 细胞系的雄激素非依赖性和 PTEN 缺失型前列腺癌模型显示出强大的临床前活性。
Toxicol Lett. 2014 Aug 4;228(3):133-9. doi: 10.1016/j.toxlet.2014.05.003. Epub 2014 May 14.
5
BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop.BENC-511,一种新型的 PI3K 抑制剂,通过调节 β-catenin/ZEB1 调控环抑制非小细胞肺癌细胞的转移。
Chem Biol Interact. 2018 Oct 1;294:18-27. doi: 10.1016/j.cbi.2018.08.010. Epub 2018 Aug 17.
6
20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway.20(S)-原人参二醇通过抑制 PI3K/Akt 信号通路触发人肺腺癌细胞 A549 中的线粒体介导的细胞凋亡。
Am J Chin Med. 2013;41(5):1137-52. doi: 10.1142/S0192415X13500778.
7
Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation.布瑞维林 A 通过线粒体途径和 PI3K/AKT/mTOR 失活诱导结肠腺癌 CT26 细胞凋亡和自噬。
Biomed Pharmacother. 2018 Feb;98:619-625. doi: 10.1016/j.biopha.2017.12.057. Epub 2017 Dec 29.
8
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.双重PI3K和mTOR抑制剂NVP-BEZ235联合甲磺酸伊马替尼对慢性粒细胞白血病细胞系的疗效。
Drug Des Devel Ther. 2017 Apr 3;11:1115-1126. doi: 10.2147/DDDT.S132092. eCollection 2017.
9
A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway.一种小分子抑制剂可抑制 D-周期蛋白的反式激活,通过磷酸肌醇 3-激酶通路在骨髓瘤和白血病的临床前研究中显示出疗效。
Blood. 2011 Feb 10;117(6):1986-97. doi: 10.1182/blood-2010-05-284810. Epub 2010 Dec 6.
10
Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells.牡荆素通过线粒体途径和 PI3K/Akt/mTOR 信号通路诱导人非小细胞肺癌 A549 细胞凋亡。
Biol Res. 2019 Feb 23;52(1):7. doi: 10.1186/s40659-019-0214-y.

引用本文的文献

1
Mechanisms of adipocyte regulation: Insights from HADHB gene modulation.脂肪细胞调节机制:来自HADHB基因调控的见解。
PLoS One. 2025 Mar 27;20(3):e0319384. doi: 10.1371/journal.pone.0319384. eCollection 2025.
2
Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway.五没食子酰葡萄糖(PGG)通过调节 ROR1 介导的 AKT-GSK3β 通路发挥抗侵袭性前列腺癌活性。
Int J Mol Sci. 2024 Jun 26;25(13):7003. doi: 10.3390/ijms25137003.
3
Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer.
受体酪氨酸激酶样孤儿受体1抑制剂蛇床子素对高侵袭性雄激素非依赖性前列腺癌具有抗癌特性。
Explor Target Antitumor Ther. 2023;4(6):1188-1209. doi: 10.37349/etat.2023.00192. Epub 2023 Dec 20.
4
MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway.MAP17 通过抑制 miR-27a-3p 的表达和 p38 信号通路促进非小细胞肺癌的进展。
Cancer Biol Ther. 2021 Jan 2;22(1):19-29. doi: 10.1080/15384047.2020.1836948. Epub 2020 Dec 7.
5
CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2.CUDC-907 通过双重抑制 PI3K/Akt/mTOR 信号通路和 HDAC2 逆转瘢痕疙瘩成纤维细胞的病理表型,在体内外均有作用。
Int J Mol Med. 2019 Nov;44(5):1789-1800. doi: 10.3892/ijmm.2019.4348. Epub 2019 Sep 23.